Abbott said on Thursday it would buy cancer test maker Exact Sciences in an up to $23 billion deal, bolstering the medical ...
WTVC NewsChannel 9 on MSN
New Colorectal screening in Chattanooga market; unbreaking fear of getting tested
Colorectal cancer is the second leading cause of cancer-related deaths in the US, despite a high survival rate when detected ...
The partnership will expedite the availability of Freenome's tests in markets outside the U.S, according to the company.
Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and ...
Analysts said the deal shows Roche’s long-term strategy for its sequencing technology is “a clinical box for running NGS kits ...
More young adults are also being diagnosed, according to Yale Medicine and the Cancer Research Institute. According to the ...
The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...
"Shield" is the first FDA-approved blood test to screen for colorectal cancer. Gretchen Carlson Spills Why Trump's 'Piggy' ...
By bringing Exact Sciences into the fold, the expectation is that the focus on cancer diagnostics can provide a jolt to the ...
Freenome has announced a strategic agreement with Roche aimed at commercialising its cancer screening technology outside the ...
In a landmark move, Abbott announced on Thursday its plan to acquire cancer test manufacturer Exact Sciences for an estimated $23 billion. This acquisition marks one of Abbott's most significant deals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback